A feature alignment score for online cone‐beam CT‐based image‐guided radiotherapy for prostate cancer. Issue 7 (8th June 2018)

• Record Type: Journal Article
• Authors: Hargrave, Catriona; Deegan, Timothy; Poulsen, Michael; Bednarz, Tomasz; Harden, Fiona; Mengersen, Kerrie
• Is Part Of: Medical physics. Volume 45:Issue 7(2018)
• Page Start: 2898
• Page End: 2911
• Publication Date: 2018-06-08
• Subjects: cone‐beam computed tomography -- decision support -- image‐guided radiotherapy -- prostate cancer; Medical physics -- Periodicals; Medical physics; Geneeskunde; Natuurkunde; Toepassingen; Biophysics; Periodicals; Periodicals; Electronic journals; 610.153
• DOI: 10.1002/mp.12980
• Languages: English
• ISSNs: 0094-2405

Abstract

Abstract : Purpose: To develop a method for scoring online cone‐beam CT (CBCT)‐to‐planning CT image feature alignment to inform prostate image‐guided radiotherapy (IGRT) decision‐making. The feasibility of incorporating volume variation metric thresholds predictive of delivering planned dose into weighted functions, was investigated. Methods: Radiation therapists and radiation oncologists participated in workshops where they reviewed prostate CBCT‐IGRT case examples and completed a paper‐based survey of image feature matching practices. For 36 prostate cancer patients, one daily CBCT was retrospectively contoured then registered with their plan to simulate delivered dose if (a) no online setup corrections and (b) online image alignment and setup corrections, were performed. Survey results were used to select variables for inclusion in classification and regression tree (CART) and boosted regression trees (BRT) modeling of volume variation metric thresholds predictive of delivering planned dose to the prostate, proximal seminal vesicles (PSV), bladder, and rectum. Weighted functions incorporating the CART and BRT results were used to calculate a score of individual tumor and organ at risk image feature alignment (FASTV _ OAR ). Scaled and weighted FASTV _ OAR were then used to calculate a score of overall treatment compliance (FASglobal ) for a given CBCT‐planning CT registration. The FASTV _ OAR were assessed for sensitivity, specificity, and predictive power. FASglobal thresholds indicative of high, medium, or low overall treatment plan compliance were determined using coefficients from multiple linear regression analysis. Results: Thirty‐two participants completed the prostate CBCT‐IGRT survey. While responses demonstrated consensus of practice for preferential ranking of planning CT and CBCT match features in the presence of deformation and rotation, variation existed in the specified thresholds for observed volume differences requiring patient repositioning or repeat bladder and bowel preparation. The CART and BRT modeling indicated that for a given registration, a Dice similarity coefficient >0.80 and >0.60 for the prostate and PSV, respectively, and a maximum Hausdorff distance <8.0 mm for both structures were predictive of delivered dose ± 5% of planned dose. A normalized volume difference <1.0 and a CBCT anterior rectum wall >1.0 mm anterior to the planning CT anterior rectum wall were predictive of delivered dose >5% of planned rectum dose. A normalized volume difference <0.88, and a CBCT bladder wall >13.5 mm inferior and >5.0 mm posterior to the planning CT bladder were predictive of delivered dose >5% of planned bladder dose. A FASTV _ OAR >0 is indicative of delivery of planned dose. For calculated FASTV _ OAR for the prostate, PSV, bladder, and rectum using test data, sensitivity was 0.56, 0.75, 0.89, and 1.00, respectively; specificity 0.90, 0.94, 0.59, and 1.00, respectively; positive predictive power 0.90, 0.86, 0.53, and 1.00, respectively; and negative predictive power 0.56, 0.89, 0.91, and 1.00, respectively. Thresholds for the calculated FASglobal of were low <60, medium 60–80, and high >80, with a 27% misclassification rate for the test data. Conclusions: A FASglobal incorporating nested FASTV _ OAR and volume variation metric thresholds predictive of treatment plan compliance was developed, offering an alternative to pretreatment dose calculations to assess treatment delivery accuracy.